Document Detail


Effect of pars plana vitrectomy for proliferative diabetic vitreoretinopathy on preexisting diabetic maculopathy.
MedLine Citation:
PMID:  11935276     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Vitrectomy is the treatment of choice for proliferative diabetic vitreoretinopathy with tractions and persistent vitreous hemorrhage. Since vitrectomy has recently been discussed as a possible therapy for diabetic maculopathy as well, we were especially interested in studying the change in diabetic maculopathy following surgery. For that purpose a grading system developed at our clinic was used. METHODS: In a retrospective study we evaluated fundus photographs and fluorescein angiograms of 33 eyes of 30 patients who had undergone vitrectomy for proliferative diabetic vitreoretinopathy at our clinic between 1990 and 1997. In all eyes diabetic maculopathy was present at the time of surgery. The grading was performed using preoperative images and images taken a median of 18 months postoperatively. RESULTS: Best corrected visual acuity increased by 3.7 lines on average. Intraretinal dot and spot hemorrhages, hard exudates, microaneurysms on fundus photos, and leakage and cysts on fluorescein angiograms decreased after surgery. The extent of the foveolar avascular zone and the extent of the perifoveolar ischemic area worsened, however. CONCLUSION: Vitrectomy seems to help diabetic eyes not only by removal of membranes, tractions, and vitreous hemorrhage; it seems to have a positive influence on the course of diabetic maculopathy as well. We suspect that the removal of the posterior vitreous membrane is one of the crucial factors in interrupting the disease process. From these results the indication for vitrectomy in diabetic patients may have to be reconsidered and extended to include diabetic maculopathy prior to the development of ischemia.
Authors:
Steffen Hoerle; Harald Poestgens; Joerg Schmidt; Peter Kroll
Related Documents :
23973646 - Olanzapine induces glucose intolerance through the activation of ampk in the mouse hypo...
24468096 - The 5-time point oral glucose tolerance test as a predictor of new-onset diabetes after...
23613566 - Glucose variability: where it is important and how to measure it.
23923576 - Amino acids differentially regulate insulin receptor tyrosine kinase and phosphatidyl i...
19146996 - Thioredoxin-1 overexpression in transgenic mice attenuates streptozotocin-induced diabe...
7829636 - The continuous low dose insulin and glucose infusion test: a simplified and accurate me...
Publication Detail:
Type:  Journal Article     Date:  2002-02-21
Journal Detail:
Title:  Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv für klinische und experimentelle Ophthalmologie     Volume:  240     ISSN:  0721-832X     ISO Abbreviation:  Graefes Arch. Clin. Exp. Ophthalmol.     Publication Date:  2002 Mar 
Date Detail:
Created Date:  2002-04-05     Completed Date:  2002-07-02     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  8205248     Medline TA:  Graefes Arch Clin Exp Ophthalmol     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  197-201     Citation Subset:  IM    
Affiliation:
Department of Ophthalmology, Philipps University Marburg, Robert-Koch-Strasse 4, 35033 Marburg, Germany. Hoerle@mailer.uni-marburg.de
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Aged, 80 and over
Diabetic Retinopathy / physiopathology,  surgery*
Female
Fluorescein Angiography
Fundus Oculi
Humans
Male
Middle Aged
Retrospective Studies
Visual Acuity
Vitrectomy*
Vitreoretinopathy, Proliferative / physiopathology*,  surgery*

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Hematologic abnormalities associated with various types of retinal vein occlusion.
Next Document:  Multifocal electroretinogram: age-related changes for different luminance levels.